-
approved in 1971 by the U.S. Food and Drug
Administration under the name
Cryoprecipitated AHF for the
Hoxworth Blood Center University of
Cincinnati Medical...
-
called cryo-poor plasma,
cryoprecipitate depleted,
cryoprecipitate reduced plasma)
refers to
plasma from
which the
cryoprecipitate has been removed. It is...
-
underlying condition.
Other measures may
include giving platelets,
cryoprecipitate, or
fresh frozen plasma.
Evidence to
support these treatments, however...
-
approved for
commercial use in 1971 in the
United States under the name
Cryoprecipitated AHF.
Together with the
development of a
system for
transportation and...
- from
whole blood or via apheresis; granulocytes;
fresh frozen plasma;
cryoprecipitates; antisera; and others. Some
products for
topical use, such as serum...
- products. The most
common of
these products are RBCs, plasma, platelets,
cryoprecipitate, and
fresh frozen plasma (FFP). FFP is quick-frozen to
retain the labile...
-
blood products administered intravenously are platelets,
blood plasma,
cryoprecipitate, and
specific coagulation factor concentrates. Many
forms of medication...
- also
exist including plasma frozen within 24
hours after phlebotomy,
cryoprecipitate reduced plasma,
thawed plasma, and
solvent detergent plasma. In the...
-
synthesis or
increased consumption.
Prothrombin complex concentrate,
cryoprecipitate and
fresh frozen plasma are
commonly used
coagulation factor products...
-
Deferasirox Complementary: Deferoxamineα
Hydroxycarbamide (hydroxyurea)α
Cryoprecipitate, pathogen-reduced
Fresh frozen plasma Platelets Red
blood cells Whole...
